PROSPECTIVE RANDOMIZED TRIAL OF RIVAROXABAN VERSUS WARFARIN IN THE EVALUATION OF PROGRESSION OF CORONARY ARTERY CALCIFICATION

Warfarin, a vitamin K antagonist, is associated with systemic vascular calcification. We hypothesized that rivaroxaban treatment is not associated with plaque progression that is observed with warfarin in patients with non-valvular atrial fibrillation. This study is prospective, single-center,